Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis
牙龈卟啉单胞菌对口腔 III 型干扰素反应的调节和操纵
基本信息
- 批准号:10595198
- 负责人:
- 金额:$ 43.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAgonistAnatomyAntiviral ResponseAntiviral resistanceBacterial InfectionsCellsChronicComplexDataDistantEpithelial CellsEpitheliumGene ExpressionGenesGingivaGoalsIRF1 geneImmuneImmune responseInfectionInflammationInflammatoryInflammatory ResponseInterferon ReceptorInterferon SuppressionInterferon Type IInterferon Type IIInterferonsLocalized DiseaseLocationMediatingMicrobeNF-kappa BNatureOncogenic VirusesOralOral cavityOral mucous membrane structureOropharyngealOutcomeParalysedPathogenicityPatientsPeptide HydrolasesPeriodontal DiseasesPeriodontitisPlayPorphyromonas gingivalisPredispositionProductionReactive Oxygen SpeciesRefractoryRegulationRoleSTAT1 geneSignal TransductionSiteSurfaceSystemic diseaseTestingTissuesViralVirulence FactorsVirusVirus Diseasesairway epitheliumantimicrobialantiviral drug developmentantiviral immunityautocrinecytokinedesensitizationdysbiosisgastrointestinalgenetic signaturegingipainin vivoinsightmouse modelneutrophilnoveloral cavity epitheliumoral tissueparacrinepromoterreceptorreceptor bindingrecruitreproductiverespiratoryrespiratory virusresponsetranscription factorviral resistance
项目摘要
ABSTRACT
This proposal addresses the nature of interferon (IFN)-based antiviral responses at the oral mucosal barrier, and
the bacterial factors that impact their efficacy. IFNs are antiviral cytokines that are critical in limiting all aspects
of viral infection. We found that Type III IFNs or IFN lambdas (IFN-λs) are preferentially expressed by oral
epithelial cells, and IFN-λ-associated signaling confers robust, broad-spectrum, antiviral immunity at the oral
mucosal barrier. Bacterial colonizers at barrier sites have the potential to modulate host susceptibility to viral
infection. Consistent with this, we found that Porphyromonas gingivalis (Pg), which is associated with oral
dysbiosis and periodontal disease, singularly and totally dampened all aspects of IFN signaling in response to
viral agonists. The overall goal of this study is to characterize the effect of Pg-induced IFN-λ suppression on
viral clearance and neutrophil function, as well as determine the relevance of IFN-λ suppression for Pg
colonization. Our main hypothesis is that IFN-λ is preferentially induced at the oral mucosal barrier and confers
antiviral immune protection without inducing inflammation. Further, we hypothesize that Pg disengages both
homeostatic and inducible IFN-λ responses, thereby enhancing host susceptibility to oral viral infection and to
chronic inflammation, as well as contributing to Pg persistence. These hypotheses will be tested in the following
specific aims. Aim 1: Characterize the impact of Pg-mediated suppression of IFN-λ signaling on viral clearance
in vivo. Aim 2: Determine the contribution of IFN-λ mediated regulation of neutrophil effector functions to tissue
damage and persistent inflammation during oral viral infections. Aim3: Determine the role of inactivation of IFN
signaling in Pg persistence during infection. This study will provide fundamental novel information on the role of
Pg in the suppression of anti-microbial inflammatory responses at the oral mucosal barrier. Additionally, an
increased understanding of the factors that provide antiviral resistance in the oral cavity is highly significant as a
large number of viruses, including SARS-Cov2, can infect oral tissues and cause local and systemic disease.
摘要
这项建议解决了基于干扰素(干扰素)的口腔粘膜屏障抗病毒反应的性质,以及
影响其疗效的细菌因素。干扰素是一种抗病毒细胞因子,在限制所有方面都是至关重要的
病毒感染的可能性。我们发现,III型干扰素或干扰素lambdas(干扰素-λS)优先通过口头表达
上皮细胞和干扰素-λ相关信号在口腔给予强大的、广谱的抗病毒免疫
粘膜屏障。屏障部位的细菌定殖体有可能调节宿主对病毒的易感性
感染。与此相一致,我们发现牙龈卟啉单胞菌(Pg)与口腔
生物失调和牙周病,特别地和完全抑制了干扰素信号的所有方面
病毒激动剂。这项研究的总体目标是表征PG诱导的干扰素-λ抑制对血管内皮细胞的影响。
病毒清除和中性粒细胞功能,以及确定干扰素-λ抑制PG的相关性
殖民主义。我们的主要假设是,干扰素-λ优先在口腔粘膜屏障诱导,并赋予
抗病毒免疫保护,不会引起炎症。此外,我们假设PG使两者脱离接触
动态平衡和可诱导的干扰素-λ反应,从而增加宿主对口腔病毒感染的易感性和
慢性炎症,也是PG持续存在的原因。这些假设将在以下方面得到验证
明确的目标。目的1:研究PG介导的干扰素-λ信号抑制对病毒清除的影响
在活体内。目的2:确定干扰素-λ介导的中性粒细胞效应功能调节对组织的贡献
口腔病毒感染期间的损害和持续性炎症。目的:确定干扰素失活的作用
感染期间PG持续存在的信号转导。这项研究将提供基本的新奇信息,关于
PG在抑制口腔粘膜屏障抗微生物炎症反应中的作用。此外,一个
增加对口腔中提供抗病毒抵抗力的因素的了解具有非常重要的意义
包括SARS-Cov2在内的大量病毒可以感染口腔组织,引起局部和全身疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Juhi Bagaitkar其他文献
Juhi Bagaitkar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Juhi Bagaitkar', 18)}}的其他基金
A T.fosythia-derived protease inhibitor in periodontal health and disease
一种源自 T.fosythia 的蛋白酶抑制剂对牙周健康和疾病的影响
- 批准号:
10447716 - 财政年份:2021
- 资助金额:
$ 43.12万 - 项目类别:
A T.fosythia-derived protease inhibitor in periodontal health and disease
一种源自 T.fosythia 的蛋白酶抑制剂对牙周健康和疾病的影响
- 批准号:
10279103 - 财政年份:2021
- 资助金额:
$ 43.12万 - 项目类别:
A T.fosythia-derived protease inhibitor in periodontal health and disease
一种源自 T.fosythia 的蛋白酶抑制剂对牙周健康和疾病的影响
- 批准号:
10673635 - 财政年份:2021
- 资助金额:
$ 43.12万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 43.12万 - 项目类别:
Research Grant














{{item.name}}会员




